DOI: 10.36347/sjmcr.2021.v09i05.031

Pages: 573-574

The pterygium is a new conjunctival triangular formation, the etio-pathogenesis is multifactorial and whose treatment is surgical but maybe complicated by postoperative recurrence. We conducted a prospective study of 52 eyes of 52 patients undergoing single pterygium by excision with conjunctival -limbic autograft, these patients were divided into two groups, the first having used non-steroidal anti-inflammatory drugs (Gp-NSAIDs) postoperatively for 1 month and the second without NSAIDs (Gp-Without). Thus, we could not demonstrate a beneficial effect of the use of non-steroidal anti-inflammatory drugs after pterygium surgery since we objected to a recurrence rate of 19% overall (15% for Gp-NSAID vs 23% for Gp- Without) with no statistically significant difference (p = 0.496) and regardless of gender or age.